Ying‐Hsu Chang
- Biomaterials top 10%
- Urology top 5%
- Oncology top 10%
- Cancer survivorship and care 5
-
- Renal cell carcinoma treatment 12
- Prostate Cancer Diagnosis and Treatment 12
- Prostate Cancer Treatment and Research 8
-
- Bladder and Urothelial Cancer Treatments 13
- Urinary and Genital Oncology Studies 7
-
- Renal and related cancers 6
-
- Pelvic floor disorders treatments 5
- Co-authors
- Chun‐Te WuWei‐Yu LinWen‐Cheng ChenMiao‐Fen ChenCheng‐Keng ChuangSee‐Tong PangHeng‐Chang ChuangMu‐Yi Hua
- Cited by
- BiomaterialsUrologyOncology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)ACS Nano (1 paper)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Ying‐Hsu Chang
49 papers receiving 798 citations
Peers
Comparison fields: 5 of 96
- Biomaterials 154
- Urology 70
- Oncology 275
- Cancer Research 106
- Pulmonary and Respiratory Medicine 212
Countries citing papers authored by Ying‐Hsu Chang
This map shows the geographic impact of Ying‐Hsu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Hsu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Hsu Chang more than expected).
Fields of papers citing papers by Ying‐Hsu Chang
This network shows the impact of papers produced by Ying‐Hsu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Hsu Chang. The network helps show where Ying‐Hsu Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying‐Hsu Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 0 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 5 | |
| 9 | 2018 | 5 | |
| 10 | 2017 | 20 | |
| 11 | 2017 | 4 | |
| 12 | 2017 | 37 | |
| 13 | 2017 | 16 | |
| 14 | 2016 | 54 | |
| 15 | 2015 | 2 | |
| 16 | 2015 | 28 | |
| 17 | 2013 | 2 | |
| 18 | 2012 | 1 | |
| 19 | 2011 | 73 | |
| 20 | 1996 | 5 |
About Ying‐Hsu Chang
Ying‐Hsu Chang is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 56 papers that have together received 808 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (13 papers), Renal cell carcinoma treatment (12 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (8 papers), Urinary and Genital Oncology Studies (7 papers), Renal and related cancers (6 papers), Pelvic floor disorders treatments (5 papers) and Cancer survivorship and care (5 papers). The work is most often cited by research in Biomaterials (154 citations), Urology (70 citations) and Oncology (275 citations). Ying‐Hsu Chang has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chun‐Te Wu, Wei‐Yu Lin, Wen‐Cheng Chen, Miao‐Fen Chen, Cheng‐Keng Chuang, See‐Tong Pang, Heng‐Chang Chuang, Mu‐Yi Hua, Rung‐Ywan Tsai and Hung‐Wei Yang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.